I am back with these bonus video shows. I am still re-adjusting myself to Zoom so if my face looks a bit funny in part 4 there is a reason. In this show I interview Stuart Ashman of Skinbiotherapeutics (SBTX), dissect that interview myself and then ask if Oacdo (OCDO) really is the Number 1 FTSE 100 short or one for the bears to dodge. I hope you enjoy the show.
You can access it for £1.49 HERE